Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities

Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities

US Patent 8969407 · Granted Mar 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Administation of ellagic acid for the treatment of canities2014
Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation2014
Administration of compounds that increase glutathione levels in the melanocytes 2013
Administration of agents mimicking dopachrome tautomerase (TRP-2) activity for p2013
Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the tre2013
Uses of BNIPXL-beta in premature canities2012
Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation2010
Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for p2009
Screening of candidates for biological hair care activity2000
Screening of candidates for biological hair care activity1999